Board approves cBHT policy
Published December 11, 2020
The APC Board of Directors has approved the alliance’s official policy statement on compounded bio-identical hormone therapy.
Highlights of the statement:
- APC opposes any additional regulation of cBHT.
- APC supports all compounded hormone therapy, with no preference for particular dosage forms.
- APC opposes restrictions that would limit hormone compounding to pharmacies that adhere to cGMP.